Shivalik Rasayan Ltd
Incorporated in 1979, Shivalik Rasayan Ltd is a manufacturer of Agrochemicals & Active Pharma Ingredients[1]
- Market Cap ₹ 720 Cr.
- Current Price ₹ 457
- High / Low ₹ 879 / 404
- Stock P/E 59.9
- Book Value ₹ 252
- Dividend Yield 0.11 %
- ROCE 4.42 %
- ROE 3.59 %
- Face Value ₹ 5.00
Pros
- Company is expected to give good quarter
- Debtor days have improved from 88.5 to 66.6 days.
- Company's working capital requirements have reduced from 120 days to 69.9 days
Cons
- Tax rate seems low
- Company has a low return on equity of 3.76% over last 3 years.
- Dividend payout has been low at 6.49% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | 41 | 43 | 41 | 44 | 48 | 61 | 85 | 99 | 94 | 94 | 149 | 164 | |
| 33 | 38 | 38 | 34 | 36 | 42 | 51 | 66 | 76 | 74 | 77 | 123 | 137 | |
| Operating Profit | 2 | 3 | 5 | 7 | 7 | 6 | 9 | 19 | 23 | 19 | 17 | 26 | 27 |
| OPM % | 6% | 7% | 11% | 17% | 17% | 13% | 16% | 22% | 23% | 20% | 18% | 18% | 16% |
| 0 | 0 | 1 | 1 | 1 | 4 | 1 | 0 | 2 | 2 | 2 | 2 | 2 | |
| Interest | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 6 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 5 | 5 | 5 | 9 | 10 |
| Profit before tax | 2 | 3 | 4 | 5 | 6 | 9 | 9 | 13 | 19 | 15 | 10 | 14 | 12 |
| Tax % | 34% | 33% | 33% | 33% | 19% | -3% | -0% | -1% | -3% | -3% | 15% | -3% | |
| 1 | 2 | 3 | 3 | 5 | 9 | 9 | 13 | 19 | 15 | 9 | 14 | 12 | |
| EPS in Rs | 1.37 | 2.10 | 3.10 | 3.84 | 4.84 | 6.47 | 6.35 | 9.20 | 13.36 | 10.42 | 5.55 | 8.81 | 7.68 |
| Dividend Payout % | 0% | 0% | 0% | 10% | 8% | 8% | 4% | 5% | 4% | 5% | 9% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 20% |
| 3 Years: | 15% |
| TTM: | 60% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 10% |
| 3 Years: | -11% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 1% |
| 3 Years: | -16% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 4% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 4 | 7 | 7 | 7 | 7 | 7 | 8 | 8 |
| Reserves | 6 | 8 | 10 | 14 | 42 | 153 | 161 | 173 | 266 | 284 | 366 | 390 |
| 0 | 0 | 11 | 14 | 8 | 9 | 0 | 11 | 15 | 40 | 55 | 71 | |
| 9 | 11 | 12 | 7 | 7 | 10 | 18 | 31 | 29 | 34 | 42 | 43 | |
| Total Liabilities | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 365 | 471 | 512 |
| 6 | 7 | 8 | 8 | 15 | 16 | 18 | 120 | 128 | 126 | 122 | 250 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 61 | 0 | 3 | 57 | 117 | 0 |
| Investments | 0 | 0 | 16 | 18 | 27 | 27 | 39 | 53 | 55 | 65 | 73 | 74 |
| 12 | 16 | 13 | 12 | 19 | 124 | 68 | 49 | 131 | 117 | 159 | 188 | |
| Total Assets | 18 | 23 | 37 | 38 | 61 | 178 | 186 | 223 | 318 | 365 | 471 | 512 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 4 | 6 | 4 | -2 | -12 | -7 | 46 | 7 | -13 | -1 | -1 | |
| 0 | -0 | -17 | -2 | -16 | -9 | -65 | -61 | -16 | -65 | -69 | -20 | |
| 0 | 1 | 7 | -2 | 19 | 104 | -9 | 10 | 76 | 21 | 83 | 22 | |
| Net Cash Flow | -0 | 4 | -4 | 1 | 2 | 83 | -81 | -5 | 66 | -57 | 13 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93 | 80 | 61 | 47 | 64 | 66 | 49 | 70 | 25 | 76 | 123 | 67 |
| Inventory Days | 8 | 5 | 14 | 22 | 36 | 82 | 33 | 45 | 97 | 256 | 328 | 268 |
| Days Payable | 103 | 126 | 139 | 76 | 66 | 92 | 166 | 119 | 108 | 154 | 102 | 114 |
| Cash Conversion Cycle | -2 | -41 | -64 | -8 | 34 | 56 | -83 | -4 | 14 | 178 | 348 | 220 |
| Working Capital Days | 17 | -11 | -47 | -37 | 38 | 154 | 202 | 4 | 58 | 129 | 163 | 70 |
| ROCE % | 23% | 29% | 28% | 25% | 18% | 9% | 6% | 7% | 8% | 5% | 4% | 4% |
Documents
Announcements
-
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30.09.2025
5 Nov - Board meeting Nov 14, 2025 to consider Q2/H1 unaudited results for period ended Sep 30, 2025.
-
Announcement Under Regulation 30
16 Oct - BSE/NSE issued warning letters for Aug 13, 2024 audit committee quorum breach; notices dated Oct 14–16, 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Oct
- Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Oct
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep - 47th AGM (27 Sep 2025): all resolutions passed; 10% final dividend; directors reappointed; secretarial auditor appointed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SRL is the largest Indian producer of Dimethoate Technical and second largest Indian producer of Malathion Technical. It also manufactures organophosphorus-based insecticides and chemicals. Apart from this, company does development of Oncology and Non-Oncology active pharmaceutical ingredients and their finished dosage forms